<DOC>
	<DOC>NCT01012570</DOC>
	<brief_summary>The investigators will study the effect of Adalimumab on the bone microstructure. - Trial with medicinal product</brief_summary>
	<brief_title>The Effect of Adalimumab on the Bone Microstructure in Crohn's Disease (CD) Patients</brief_title>
	<detailed_description />
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Adalimumab</mesh_term>
	<criteria>Inclusion criteria: CDAI &gt; 220 und &lt; 450 Biologika naiv CD seit &gt; 6 Monaten Exclusion criteria: other TNFBlocker Steroids &gt; 40 mg Malignoma in der Anamnesis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>